UK markets open in 36 minutes

Agios Pharmaceuticals, Inc. (AGIO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
33.88+0.69 (+2.08%)
At close: 04:00PM EDT
33.88 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
29,403
26,823
14,240
0
0
-
Cost of revenue
2,954
2,881
1,704
0
2,805
-
Gross profit
26,449
23,942
12,536
0
200,391
-
Operating expenses
Research development
296,845
295,526
279,910
256,973
220,811
-
Selling general and administrative
122,550
119,903
121,673
121,445
115,105
-
Total operating expenses
419,395
415,429
401,583
378,418
335,916
-
Operating income or loss
-392,946
-391,487
-389,047
-378,418
-335,916
-
Interest expense
-
-
-
-
17,832
0
Total other income/expenses net
6,185
6,055
144,453
21,072
-
-
Income before tax
-352,619
-352,088
-231,801
-356,510
-329,305
-
Income from continuing operations
-352,619
-352,088
-231,801
-356,510
-329,305
-
Net income
-352,619
-352,088
-231,801
1,604,715
-327,370
-
Net income available to common shareholders
-352,619
-352,088
-231,801
1,604,715
-327,370
-
Basic EPS
-3.94
-
-4.23
26.55
-4.74
-6.86
Diluted EPS
-3.94
-
-4.23
26.55
-4.74
-6.86
Basic average shares
55,409
-
54,789
60,447
68,998
59,995
Diluted average shares
55,409
-
54,789
60,447
68,998
59,995